↓ Skip to main content

Adverse event profiles of dipeptidyl peptidase-4 inhibitors: data mining of the public version of the FDA adverse event reporting system

Overview of attention for article published in BMC Pharmacology and Toxicology, September 2020
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
66 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Adverse event profiles of dipeptidyl peptidase-4 inhibitors: data mining of the public version of the FDA adverse event reporting system
Published in
BMC Pharmacology and Toxicology, September 2020
DOI 10.1186/s40360-020-00447-w
Pubmed ID
Authors

Jing Huang, Yuntao Jia, Shusen Sun, Long Meng

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 66 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 66 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 12 18%
Student > Bachelor 6 9%
Researcher 6 9%
Student > Ph. D. Student 5 8%
Lecturer 3 5%
Other 7 11%
Unknown 27 41%
Readers by discipline Count As %
Medicine and Dentistry 10 15%
Pharmacology, Toxicology and Pharmaceutical Science 9 14%
Nursing and Health Professions 4 6%
Biochemistry, Genetics and Molecular Biology 2 3%
Agricultural and Biological Sciences 1 2%
Other 8 12%
Unknown 32 48%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 May 2022.
All research outputs
#14,063,113
of 23,312,088 outputs
Outputs from BMC Pharmacology and Toxicology
#184
of 449 outputs
Outputs of similar age
#195,934
of 376,902 outputs
Outputs of similar age from BMC Pharmacology and Toxicology
#4
of 10 outputs
Altmetric has tracked 23,312,088 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 449 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one has gotten more attention than average, scoring higher than 58% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 376,902 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than 6 of them.